Leading the way to safer medication
 Crosscheck  Recommender

ADTRALZA

Found in: United Kingdom

Active Ingredients

#
Chemical substance
Description
1
Tralokinumab

Tralokinumab is a fully human IgG4 monoclonal antibody that specifically binds to the type 2 cytokine interleukin-13 (IL-13) and inhibits its interaction with the IL-13 receptors. IL-13 is a major driver of human type 2 inflammatory disease, such as atopic dermatitis and inhibiting the IL-13 pathway with tralokinumab in patients decreases many of the mediators of type 2 inflammation.

ATC Classification

Code
Title
Category
D11AH07
Tralokinumab
D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AH Agents for dermatitis, excluding corticosteroids

Product Monographs

Monograph
Type
Country
ADTRALZA Solution for injection
MPI, EU: SmPC
UK